18 results on '"Djafari, L."'
Search Results
2. Dose-dense regimen of temozolomide given every other week in patients with primary central nervous system tumors
3. Assessment of tumor angiogenesis as a prognostic factor of survival in patients with oligodendroglioma
4. Multivariate Assessment of Tumor Angiogenesis as a Prognostic Factor for Survival in Patients with Oligodendroglioma and Anaplastic Oligodendroglioma
5. Phase I study of temozolomide in combination with topotecan (TOTEM) in children with refractory or relapsed malignant tumors
6. Phase II trial of pegylated liposomal doxorubicin-cyclophosphamide combination as first-line chemotherapy in elderly metastatic breast cancer patients
7. Phase I of high dose (HD) temozolomide (TMZ) with peripheral blood stem cell support (PBSCS) rescue in recurrent high grade glioma (HGG)
8. Phase II Trial of Pegylated Liposomal Doxorubicin-Cyclophosphamide Combination as First-Line Chemotherapy in Older Metastatic Breast Cancer Patients
9. Temozolomide phase II study in children with relapsing refractory high-risk neuroblastoma
10. 60 Pathological and radiological assessment of tumor angiogenesis as prognostic factors of survival in patients with oligodendrogliomas
11. Dose finding and O6-alkylguanine-DNA alkyltransferase study of cisplatin combined with temozolomide in paediatric solid malignancies
12. Initial chemotherapy in gliomatosis cerebri
13. Baseline pathological and radiological assessment of tumor angiogenesis predicts survival in patients with oligodendrogliomas
14. Bernhard Gottlieb: his life, his work, and his lasting impact.
15. Phase I study of topotecan in combination with temozolomide (TOTEM) in relapsed or refractory paediatric solid tumours.
16. Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.
17. Phase I dose escalation study of pegylated liposomal doxorubicin (Caelyx) in combination with topotecan in patients with advanced malignancies.
18. Locoregional effects of pegylated liposomal doxorubicin (Caelyx) in irradiated area: a phase I-II study in patients with recurrent squamous cell carcinoma of the head and neck.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.